The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

Feed excerpt — reported by NPR Politics

It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at NPR Politics →

View MAP Context →